biricodar biricodar biricodar or incel (inn, codename vx-710) was a pharmaceutical drug under development by vertex pharmaceuticals to help treat ovarian cancer patients, that never reached the market. biricodarclinical dataatc codenoneidentifiers iupac name 1,7-di(pyridin-3-yl)heptan-4-yl (2s)-1-piperidine-2-carboxylate cas number174254-13-8 ypubchem cid3037617chemspider2301309 yunii9wqp0l619lchemblchembl350775 ycomptox dashboard (epa)dtxsid50893944 chemical and physical dataformulac34h41n3o7molar mass603.716 g·mol−13d model (jsmol)interactive image smiles o=c(c(=o)c1cc(oc)c(oc)c(oc)c1)n4(c(=o)oc(cccc2cccnc2)cccc3cccnc3)cccc4 inchi inchi=1s/c34h41n3o7/c1-41-29-20-26(21-30(42-2)32(29)43-3)31(38)33(39)37-19-5-4-16-28(37)34(40)44-27(14-6-10-24-12-8-17-35-22-24)15-7-11-25-13-9-18-36-23-25/h8-9,12-13,17-18,20-23,27-28h,4-7,10-11,14-16,19h2,1-3h3/t28-/m0/s1 ykey:cgvwpqofhsakrr-ndephwfrsa-n y (verify)